TipRanks
Advertisement
Advertisement

LTRN Stock Latest News

Lantern Pharma Faces Nasdaq Non-Compliance, Delisting Risk
Company AnnouncementsLantern Pharma Faces Nasdaq Non-Compliance, Delisting Risk
2d ago
8K
LTRN
Lantern Pharma Raises Capital Through Recent Securities Offerings
PremiumCompany Announcements
Lantern Pharma Raises Capital Through Recent Securities Offerings
3d ago
8K
LTRN
Lantern Pharma prices 3.67M shares at $1.09 in registered direct offering
PremiumThe Fly
Lantern Pharma prices 3.67M shares at $1.09 in registered direct offering
4d ago
LTRN
Lantern Pharma Highlights Open-Medicine AI Oncology Platform
PremiumCompany Announcements
Lantern Pharma Highlights Open-Medicine AI Oncology Platform
9d ago
8K
LTRN
Lantern Pharma Showcases Open-Medicine AI Growth Strategy
PremiumCompany Announcements
Lantern Pharma Showcases Open-Medicine AI Growth Strategy
10d ago
8K
LTRN
Lantern Pharma secures USPTO notice of allowance for LP-284 patent
PremiumThe FlyLantern Pharma secures USPTO notice of allowance for LP-284 patent
11d ago
LTRN
Lantern Pharma to host webinar on Open-Medicine AI
Premium
The Fly
Lantern Pharma to host webinar on Open-Medicine AI
16d ago
LTRN
Lantern Pharma Earnings Call: AI Spinout, Trial Momentum
Premium
Company Announcements
Lantern Pharma Earnings Call: AI Spinout, Trial Momentum
1M ago
LTRN
Lantern Pharma reports Q2 EPS (57c) vs (40c) last year
PremiumThe Fly
Lantern Pharma reports Q2 EPS (57c) vs (40c) last year
2M ago
LTRN
Lantern Pharma Forms Open Medicine AI Subsidiary Business
PremiumCompany Announcements
Lantern Pharma Forms Open Medicine AI Subsidiary Business
2M ago
8K
LTRN
Lantern Pharma, Inc. (LTRN) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Lantern Pharma, Inc. (LTRN) Q2 Earnings Cheat Sheet
2M ago
LTRN
Lantern Pharma Spins Off Open-Medicine AI Platform
PremiumCompany Announcements
Lantern Pharma Spins Off Open-Medicine AI Platform
2M ago
8K
LTRN
Lantern Pharma establishes Open-Medicine AI as separate company
PremiumThe FlyLantern Pharma establishes Open-Medicine AI as separate company
2M ago
LTRN
Lantern Pharma to advance EMA-cleared Phase 1b/2 trial of LP-184
Premium
The Fly
Lantern Pharma to advance EMA-cleared Phase 1b/2 trial of LP-184
2M ago
LTRN
Lantern Pharma receives USPTO notice of allowance for patent of LP-184
Premium
The Fly
Lantern Pharma receives USPTO notice of allowance for patent of LP-184
2M ago
LTRN
Lantern Pharma launches ZetaOmics computational-biology module
PremiumThe Fly
Lantern Pharma launches ZetaOmics computational-biology module
3M ago
LTRN
Lantern Pharma files to sell 2.24M shares of common stock for holders
PremiumThe Fly
Lantern Pharma files to sell 2.24M shares of common stock for holders
4M ago
LTRN
Lantern Pharma reports data, updates from Phase 2 Harmonic trial on LP-300
PremiumThe Fly
Lantern Pharma reports data, updates from Phase 2 Harmonic trial on LP-300
4M ago
LTRN
Lantern Pharma Highlights Harmonic LP-300 Phase 2 Progress
PremiumCompany Announcements
Lantern Pharma Highlights Harmonic LP-300 Phase 2 Progress
4M ago
8K
LTRN
Lantern receives successful response to Type C meeting from FDA on LP-300
PremiumThe FlyLantern receives successful response to Type C meeting from FDA on LP-300
5M ago
LTRN
Lantern Pharma raises capital, plans AI platform spinoff
Premium
Company Announcements
Lantern Pharma raises capital, plans AI platform spinoff
5M ago
8K
LTRN
Lantern Pharma prices 2.14M shares at $2.06 in registered direct offering
Premium
The Fly
Lantern Pharma prices 2.14M shares at $2.06 in registered direct offering
5M ago
LTRN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >